Last updated: 2026-11-14 12:00:01. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
electroCore, Inc. (ECOR) operates in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $5.20, with a market capitalization of $48.81M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $4.37 to $12.70. This page covers its latest market performance, valuation, price trends and company information.
$48.81M | |
$5.42 | |
$5.58 | |
$4.45 | |
$5.29 | |
282.91K | |
103.94K | |
-- | |
$12.70 | |
$4.37 | |
-- | |
-- |
electroCore, Inc. (ECOR) last closed at $5.20 as of 2026-11-14 00:31:00, down 1.70% ($0.09) from the previous close of $5.29.
During the latest regular trading session, ECOR traded between $4.45 and $5.58, with a volume of 282.91K shares. The closing price was near the upper end and near the lower end of its 52-week range.
ECOR is down 1.70% as of the last close.
Over the past seven days, electroCore, Inc. (ECOR) moved from $8.80 to $5.20, representing a decline of 40.94% ($3.60).
The stock traded between $4.37 and $9.00 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 258.88 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 9.9%
ECOR is currently trading at $5.20, placing it 9.9% of the way from its 52-week low of $4.37 to its 52-week high of $12.70. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
| Industry | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
| Employees | 83 |
| Exchange | NASDAQ |
| Company Website |
Latest news related to electroCore, Inc. and ECOR stock.
Gainers Addex Therapeutics (NASDAQ:ADXN) stock moved upwards by 73.5% to $5.01 during Thursday's regular session. enGene Therapeutics (NASDAQ:ENGN) stock rose 29.37% to $2.33. The company's market cap stands
electroCore and Sonocea published results from a randomized controlled trial evaluating non-invasive neuromodulation technologies for Long COVID treatment. The study of 250 participants showed improvements in fatigue, cognition, sleep, and mental health symptoms across active intervention groups compared to monitoring-only controls, with depressive symptoms decreasing 31-34% and PTSD symptoms reducing 39% with combined therapy. However, the open-label design without sham control and reliance on patient-reported outcomes limit the findings, which are considered hypothesis-generating and warrant confirmation in larger, sham-controlled studies.
Eligible investors can buy real shares of electroCore, Inc. (ECOR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
See US stocks with the highest market capitalization
Discover today's most actively traded US stocks
Browse today's leading gainers in the US stock market
Explore the cryptocurrencies with the highest market capitalization
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to ECOR, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between ECOR shares and USD.
ECOR Shares to USD
1.00 ECOR shares = 5.197 USD
Calculations are estimates based on the latest available price and are for reference only.
